The Effects Of Change And Re Evaluation Of The Process And...

Feedback about the effects of the change and re-evaluation of the process and the expected outcomes is vital and coincides with the quality improvement activities within the practice (Dontje, 2007). Setting The EBP will be conducted in Providence Hospital (PH), a 408-bed facility in Washington, DC that offers care in a variety of medical specialties (Bariatric Services and Wellness programs, Behavioral Health, Cardiology, Diabetes, Emergency Services, Geriatric Medicine, Oncology and Orthopedics). The EBP will use six of the 14 nursing units to pilot the proposed intervention. The pilot six nursing units will be chosen after a review of the hospital’s patient handling workers compensation claims that occurred during the previous year. The†¦show more content†¦Data Collection Methods Study participants will use paper and pencil to complete the Keele STarT Back Screening Tool (SBST). The SBST is a simple prognostic questionnaire that helps the lead EBP investigator to identify modifiable risk factors (biomedical, psychological and social) for back pain disability for participants 40 years of age and older. The SBST takes approximately 2 minutes to complete. Keele University, the creator of the SBST, grants permission for the tool to be used from its website â€Å"use of this tool is free and open to all - no license is required†. However, when using the tool, Keele University asked that copyright and funding statement is maintained at all times. The SBST has 9 questions about predictors for persistent disabling back pain that includes radiating leg pain, pain elsewhere, disability (2 items), fear, anxiety, pessimistic patient expectations, low mood, and how much the patient is bothered by their pain (Keele University, 2008). All 9-items use a response format of ‘agree or ‘disagree , with exception of the last question, which uses a Likert scale. The Keele SBST produces two scores: overall (total score) and distress (psych) sub-scale score. The scores stratify patients into low, medium, or high risk categories. The 9-item clinical measurement tool is designed to help the lead EBP investigator to